During the past decade, Arizona Oncology - HOPE Wilmot conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 9 clinical trials were completed, i.e. on average, 81.8% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 7 clinical trials were completed. i.e. 175% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Arizona Oncology - HOPE Wilmot" #1 sponsor was "Hoffmann-La Roche" with 4 trials, followed by "Incyte Corporation" with 2 trials sponsored, "Agenus Inc." with 1 trials sponsored, "Bristol-Myers Squibb" with 1 trials sponsored and "GOG Foundation" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Arizona Oncology - HOPE Wilmot" #1 collaborator was "GOG Foundation" with 3 trials as a collaborator, "European Network of Gynaecological Oncological Trial Groups (ENGOT)" with 2 trials as a collaborator, "National Cancer Institute (NCI)" with 2 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator and "NRG Oncology" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Arizona Oncology - HOPE Wilmot" are "Bladder Cancer" (2 trials), "Ovarian Cancer" (2 trials), "Cervical Adenocarcinoma" (1 trials), "Cervical Adenosquamous Carcinoma" (1 trials) and "Cervical Cancer" (1 trials). Many other conditions were trialed in "Arizona Oncology - HOPE Wilmot" in a lesser frequency.

Most popular intervention types in "Arizona Oncology - HOPE Wilmot" are "Drug" (12 trials), "Other" (3 trials), "Biological" (2 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (5 trials), "Paclitaxel" (5 trials), "Carboplatin" (4 trials), "Quality-of-Life Assessment" (3 trials) and "Bevacizumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Arizona Oncology - HOPE Wilmot" are 6 trials for "Female" genders, 5 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Arizona Oncology - HOPE Wilmot". undefined are not yet recruiting, 2 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Arizona Oncology - HOPE Wilmot, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Arizona Oncology - HOPE Wilmot, 1 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".